Skip to main content
. 2021 Oct 28;14:143. doi: 10.1186/s13048-021-00900-2

Table 2.

Details in controlled ovarian hyper-stimulation (COH) and oocyte retrieval in IVF

AFC PFC OR FORT ORR Total Gn dose (IU) Gn/day (IU) COH days Gn/Weight (IU/kg) Ovulation triggering medication /ovulation triggering-to-harvest interval
Patient 1 Cycle 1 (at 32yo) a N/A 6 0 N/A 0 N/A N/A N/A N/A N/A / 36hours
Patient 1 Cycle 2 (at 32yo) 12 2 1 0.16 0.50 4050 368 11 73 GnRH agonist 0.1mg+rhCG 250mcg / 40hours
Patient 2 Cycle 1 (at32yo) 13 7 1 0.54 0.14 9600c 457 21 147 GnRH agonist 0.1mg+rhCG 250mcg / 36hours
Patient 2 Cycle 2 (at 32yo) 7 7 3 1.00 0.42 8850c 491 18 136 GnRH agonist 0.1mg+rhCG 250mcg / 36hours
Controls b 8.2 6.5 6.8 0.91 1.03 2362 254 9.4 43 Varied

AFC Antral follicle count, PFC Preovulatory follicle count, number of follicles ≥14mm at triggering day, OR Number of oocytes retrieved, FORT Follicular output rate = PFC/AFC ×100%, ORR Oocyte retrieval rate = number of OR/PFC ×100%, Gn Gonadotropin

a Patient 1 cycle 1 was done at another centre, and therefore some clinical data was not available

bAveraged data from our IVF centre, calculated from all cycles done in the same year for same-aged patients

cClomiphene citrate was used simultaneously